Form D · Other Health Care
OROGEN BIOSCIENCES INC
Ft. Myers, FL · CIK 0001445417
Offering snapshot reported Feb 16, 2010 · SEC filing
- Reported sold
- Yet to sell Offering amount: $1M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 16, 2010 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Sep 12, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06, 46
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-122674
Source: Form D, filed Feb 16, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Brandt | Director, Executive, Promoter |
| Ryan Brandt | Director, Executive, Promoter |
| Clark Galen | Director, Executive, Promoter |
| James Gandy | Executive |
| Joseph Greco | Director, Executive, Promoter |
| John Kwiczak | Director, Executive, Promoter |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
11220 Metro Parkway, Suite 1 Suite 1
Ft. Myers, FL, 33966
Ft. Myers, FL, 33966